Literature DB >> 18954912

GABA, a natural immunomodulator of T lymphocytes.

Helen Bjurstöm1, JunYang Wang, Junyang Wang, Ida Ericsson, Martin Bengtsson, Yawei Liu, Suresh Kumar-Mendu, Shohreh Issazadeh-Navikas, Bryndis Birnir.   

Abstract

gamma-aminobutyric acid (GABA) is the main neuroinhibitory transmitter in the brain. Here we show that GABA in the extracellular space may affect the fate of pathogenic T lymphocytes entering the brain. We examined in encephalitogenic T cells if they expressed functional GABA channels that could be activated by the low (nM-1 microM), physiological concentrations of GABA present around neurons in the brain. The cells expressed the alpha1, alpha4, beta2, beta3, gamma1 and delta GABAA channel subunits and formed functional, extrasynaptic-like GABA channels that were activated by 1 microM GABA. 100 nM and higher GABA concentrations decreased T cell proliferation. The results are consistent with GABA being immunomodulatory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954912     DOI: 10.1016/j.jneuroim.2008.08.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  72 in total

Review 1.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

Review 2.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  Distribution and quantitative detection of GABAA receptor in Carassius auratus gibelio.

Authors:  Jiming Ruan; Kun Hu; Haixin Zhang; Yi Wang; Ailing Zhou; Yini Zhao; Xianle Yang
Journal:  Fish Physiol Biochem       Date:  2014-04-01       Impact factor: 2.794

4.  Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABAA Receptor Modulators.

Authors:  Gloria S Forkuo; Amanda N Nieman; Nina Y Yuan; Revathi Kodali; Olivia B Yu; Nicolas M Zahn; Rajwana Jahan; Guanguan Li; Michael Rajesh Stephen; Margaret L Guthrie; Michael M Poe; Benjamin D Hartzler; Ted W Harris; Gene T Yocum; Charles W Emala; Douglas A Steeber; Douglas C Stafford; James M Cook; Leggy A Arnold
Journal:  Mol Pharm       Date:  2017-05-01       Impact factor: 4.939

Review 5.  Structure, function, and modulation of GABA(A) receptors.

Authors:  Erwin Sigel; Michael E Steinmann
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

6.  GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes.

Authors:  Nepton Soltani; Hongmin Qiu; Mila Aleksic; Yelena Glinka; Fang Zhao; Rui Liu; Yiming Li; Nina Zhang; Rabindranath Chakrabarti; Tiffany Ng; Tianru Jin; Haibo Zhang; Wei-Yang Lu; Zhong-Ping Feng; Gerald J Prud'homme; Qinghua Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

7.  A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung.

Authors:  Gloria S Forkuo; Amanda N Nieman; Revathi Kodali; Nicolas M Zahn; Guanguan Li; M S Rashid Roni; Michael Rajesh Stephen; Ted W Harris; Rajwana Jahan; Margaret L Guthrie; Olivia B Yu; Janet L Fisher; Gene T Yocum; Charles W Emala; Douglas A Steeber; Douglas C Stafford; James M Cook; Leggy A Arnold
Journal:  Mol Pharm       Date:  2018-04-02       Impact factor: 4.939

8.  Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Roxana del Rio; Rajkumar Noubade; Cory Teuscher
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

9.  Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments.

Authors:  Gloria S Forkuo; Margaret L Guthrie; Nina Y Yuan; Amanda N Nieman; Revathi Kodali; Rajwana Jahan; Michael R Stephen; Gene T Yocum; Marco Treven; Michael M Poe; Guanguan Li; Olivia B Yu; Benjamin D Hartzler; Nicolas M Zahn; Margot Ernst; Charles W Emala; Douglas C Stafford; James M Cook; Leggy A Arnold
Journal:  Mol Pharm       Date:  2016-05-10       Impact factor: 4.939

10.  Sedation improves early outcome in severely septic Sprague Dawley rats.

Authors:  Hong Qiao; Robert D Sanders; Daqing Ma; Xinmin Wu; Mervyn Maze
Journal:  Crit Care       Date:  2009-08-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.